- Home
- BLFS
as 12-18-2024 10:32am EST
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | BOTHELL |
| Market Cap: | 1.2B | IPO Year: | 1989 |
| Target Price: | $28.29 | AVG Volume (30 days): | 406.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.01 | EPS Growth: | N/A |
| 52 Week Low/High: | $14.50 - $28.88 | Next Earning Date: | 11-12-2024 |
| Revenue: | $146,957,000 | Revenue Growth: | 16.40% |
| Revenue Growth (this year): | -23.07% | Revenue Growth (next year): | -9.12% |
Stock Insider Trading Activity of BioLife Solutions Inc. (BLFS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Aebersold Sarah | BLFS | Chief Human Resources Officer | Nov 26 '24 | Sell | $27.20 | 216 | $5,875.20 | 60,484 | |
| Berard Todd | BLFS | Chief Marketing Officer | Nov 26 '24 | Sell | $27.20 | 349 | $9,492.80 | 107,407 | |
| Foster Karen A. | BLFS | Chief Quality and Operations | Nov 26 '24 | Sell | $27.20 | 252 | $6,854.40 | 156,973 | |
| Mathew Aby J. | BLFS | EVP & Chief Scientific Officer | Nov 26 '24 | Sell | $27.20 | 523 | $14,225.60 | 283,919 | |
| Wichterman Troy | BLFS | Chief Financial Officer | Nov 26 '24 | Sell | $27.20 | 581 | $15,803.20 | 122,766 | |
| Mathew Aby J. | BLFS | EVP & Chief Scientific Officer | Nov 15 '24 | Sell | $20.79 | 42,604 | $882,110.20 | 283,919 | |
| Berard Todd | BLFS | Chief Marketing Officer | Nov 12 '24 | Sell | $26.34 | 91 | $2,396.94 | 107,407 | |
| Foster Karen A. | BLFS | Chief Quality and Operations | Nov 12 '24 | Sell | $26.34 | 66 | $1,738.44 | 156,973 | |
| Mathew Aby J. | BLFS | EVP & Chief Scientific Officer | Nov 12 '24 | Sell | $26.34 | 123 | $3,239.82 | 283,919 | |
| Wichterman Troy | BLFS | Chief Financial Officer | Nov 12 '24 | Sell | $26.19 | 147 | $3,849.93 | 122,766 |
Latest BioLife Solutions Inc. News
BLFS Breaking Stock News: Dive into BLFS Ticker-Specific Updates for Smart Investing
PR Newswire
2 days ago
BioLife Solutions Appoints Tony J. Hunt to its Board of Directors
Simply Wall St.
5 days ago
3 US Stocks Estimated To Be Trading At Discounts Up To 40.9%
Argus Research
8 days ago
BLFS: Rating increased to a HOLD
Simply Wall St.
13 days ago
Estimating The Intrinsic Value Of BioLife Solutions, Inc. (NASDAQ:BLFS)
Argus Research
15 days ago
BLFS: What does Argus have to say about BLFS?
Argus Research
22 days ago
BLFS: Raising target price to $24.00
MT Newswires
a month ago
Biolife Solutions Insider Sold Shares Worth $882,110, According to a Recent SEC Filing
Simply Wall St.
a month ago
BioLife Solutions, Inc. (NASDAQ:BLFS) Just Reported And Analysts Have Been Cutting Their Estimates
Compare BLFS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BLFS BioLife Solutions Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.